Ultragen’s Stop device
This article was originally published in The Rose Sheet
Executive SummaryUltragen is launching skin-renewal device Stop in France after partnering with French equipment supplier Logicom, according to Sept. 2 release. Hand-held Stop device offers consumers the opportunity to enjoy at home the aesthetic benefits of focused TriPollar radiofrequency originally developed for use exclusively in professional settings. According to Dr. Zion Azar, founder of Ultragen and creator of TriPollar, "Logicom has already secured a seven-figure order for the Stop, and we look forward to developing business in [France] further." Logicom will be responsible for overseeing retail partners and building long-term business relationships, Ultragen notes. Stop device, touted as an alternative to invasive surgical techniques for skin tightening, firming and renewal, is slated to launch in upscale UK department stores later this year (1"The Rose Sheet," Sept. 1, 2008, p. 9)
You may also be interested in...
Strides has set a sales target of $200-400m for Stelis’s generic injectables business in two to four years as part of its plan to reach $800m in total revenues in four years. Meanwhile, Stelis’s Rh-teriparatide for osteoporosis and sodium hyaluronate for osteoarthritis await Phase III incremental studies in the US.